Ongentys and Kynmobi Will Be New Meds for Parkinson's Disease

Ongentys (opicapone) and Kynmobi (apomorphine) will add to the growing list of meds for Parkinson's disease.

They're for "off" episodes...when symptoms (tremor, etc) return between carbidopa/levodopa doses, especially as Parkinson's progresses.

Expect these meds to be saved for when dose adjustments of carbidopa/levodopa don't help...or other add-ons (pramipexole, rasagiline, etc) aren't enough or aren't tolerated.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote